These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
9. Regulation of IL-8 and IL-1beta expression in Crohn's disease associated NOD2/CARD15 mutations. Li J; Moran T; Swanson E; Julian C; Harris J; Bonen DK; Hedl M; Nicolae DL; Abraham C; Cho JH Hum Mol Genet; 2004 Aug; 13(16):1715-25. PubMed ID: 15198989 [TBL] [Abstract][Full Text] [Related]
10. Impaired antibacterial autophagy links granulomatous intestinal inflammation in Niemann-Pick disease type C1 and XIAP deficiency with NOD2 variants in Crohn's disease. Schwerd T; Pandey S; Yang HT; Bagola K; Jameson E; Jung J; Lachmann RH; Shah N; Patel SY; Booth C; Runz H; Düker G; Bettels R; Rohrbach M; Kugathasan S; Chapel H; Keshav S; Elkadri A; Platt N; Muise AM; Koletzko S; Xavier RJ; Marquardt T; Powrie F; Wraith JE; Gyrd-Hansen M; Platt FM; Uhlig HH Gut; 2017 Jun; 66(6):1060-1073. PubMed ID: 26953272 [TBL] [Abstract][Full Text] [Related]
11. RNAi screening identifies mediators of NOD2 signaling: implications for spatial specificity of MDP recognition. Lipinski S; Grabe N; Jacobs G; Billmann-Born S; Till A; Häsler R; Aden K; Paulsen M; Arlt A; Kraemer L; Hagemann N; Erdmann KS; Schreiber S; Rosenstiel P Proc Natl Acad Sci U S A; 2012 Dec; 109(52):21426-31. PubMed ID: 23213202 [TBL] [Abstract][Full Text] [Related]
12. Engagement of NOD2 has a dual effect on proIL-1beta mRNA transcription and secretion of bioactive IL-1beta. Ferwerda G; Kramer M; de Jong D; Piccini A; Joosten LA; Devesaginer I; Girardin SE; Adema GJ; van der Meer JW; Kullberg BJ; Rubartelli A; Netea MG Eur J Immunol; 2008 Jan; 38(1):184-91. PubMed ID: 18157816 [TBL] [Abstract][Full Text] [Related]
13. NOD2 modulates immune tolerance via the GM-CSF-dependent generation of CD103 Prescott D; Maisonneuve C; Yadav J; Rubino SJ; Girardin SE; Philpott DJ Proc Natl Acad Sci U S A; 2020 May; 117(20):10946-10957. PubMed ID: 32350141 [TBL] [Abstract][Full Text] [Related]
14. Hyperexpression of NOD2 in intestinal mast cells of Crohn's disease patients: preferential expression of inflammatory cell-recruiting molecules via NOD2 in mast cells. Okumura S; Yuki K; Kobayashi R; Okamura S; Ohmori K; Saito H; Ra C; Okayama Y Clin Immunol; 2009 Feb; 130(2):175-85. PubMed ID: 18938111 [TBL] [Abstract][Full Text] [Related]
15. Synergy between TLR9 and NOD2 innate immune responses is lost in genetic Crohn's disease. van Heel DA; Ghosh S; Hunt KA; Mathew CG; Forbes A; Jewell DP; Playford RJ Gut; 2005 Nov; 54(11):1553-7. PubMed ID: 15928043 [TBL] [Abstract][Full Text] [Related]
16. Pathogen sensing by nucleotide-binding oligomerization domain-containing protein 2 (NOD2) is mediated by direct binding to muramyl dipeptide and ATP. Mo J; Boyle JP; Howard CB; Monie TP; Davis BK; Duncan JA J Biol Chem; 2012 Jun; 287(27):23057-67. PubMed ID: 22549783 [TBL] [Abstract][Full Text] [Related]
17. Distinct roles for Nod2 protein and autocrine interleukin-1beta in muramyl dipeptide-induced mitogen-activated protein kinase activation and cytokine secretion in human macrophages. Hedl M; Abraham C J Biol Chem; 2011 Jul; 286(30):26440-9. PubMed ID: 21659536 [TBL] [Abstract][Full Text] [Related]
18. Peptidoglycan Metabolite Photoaffinity Reporters Reveal Direct Binding to Intracellular Pattern Recognition Receptors and Arf GTPases. Wang YC; Westcott NP; Griffin ME; Hang HC ACS Chem Biol; 2019 Mar; 14(3):405-414. PubMed ID: 30735346 [TBL] [Abstract][Full Text] [Related]
19. Identification of a synthetic muramyl peptide derivative with enhanced Nod2 stimulatory capacity. Rubino SJ; Magalhaes JG; Philpott D; Bahr GM; Blanot D; Girardin SE Innate Immun; 2013 Oct; 19(5):493-503. PubMed ID: 23339926 [TBL] [Abstract][Full Text] [Related]
20. Enhancement of Muramyl Dipeptide-Dependent NOD2 Activity by a Self-Derived Peptide. Mann JK; Shen J; Park S J Cell Biochem; 2017 May; 118(5):1227-1238. PubMed ID: 27791288 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]